Marc Patrick Reichenberger
No más puestos en curso
Perfil
Mr. Marc P.
Reichenberger is Vice President-Commercial Operations at Raptor Therapeutics, Inc. and Vice President-Commercial Operations at Raptor Pharmaceutical Corp.
Mr. Reichenberger was previously employed as Senior Director by Xoma.
He received his undergraduate degree from the University of California, Los Angeles and an MBA from Pepperdine University.
Antiguos cargos conocidos de Marc Patrick Reichenberger.
Empresas | Cargo | Fin |
---|---|---|
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Director/Miembro de la Junta | 01/05/2010 |
RAPTOR PHARMACEUTICAL CORP | Corporate Officer/Principal | - |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Corporate Officer/Principal | - |
Formación de Marc Patrick Reichenberger.
Pepperdine University | Masters Business Admin |
University of California, Los Angeles | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Marc Patrick Reichenberger